SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-004193
Filing Date
2015-05-13
Accepted
2015-05-13 16:34:48
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kura-10q_20150331.htm 10-Q 899332
2 EX-10.6 kura-ex106_20150331667.htm EX-10.6 19442
3 EX-31.1 kura-ex311_2015033184.htm EX-31.1 15587
4 EX-31.2 kura-ex312_2015033185.htm EX-31.2 15563
5 EX-32.1 kura-ex321_2015033186.htm EX-32.1 8195
  Complete submission text file 0001564590-15-004193.txt   3540699

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kura-20150331.xml EX-101.INS 323999
7 XBRL TAXONOMY EXTENSION SCHEMA kura-20150331.xsd EX-101.SCH 33683
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kura-20150331_cal.xml EX-101.CAL 27988
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kura-20150331_def.xml EX-101.DEF 98859
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20150331_lab.xml EX-101.LAB 231043
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20150331_pre.xml EX-101.PRE 174979
Mailing Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037
Business Address 11119 N. TORREY PINES ROAD, STE 125 LA JOLLA CA 92037 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53058 | Film No.: 15858885
SIC: 2834 Pharmaceutical Preparations